Cross-border advisory

Mercurity Fintech (MFH) subsidiary Chaince Securities secured a corporate advisory role for an Asia-Pacific healthcare firm’s U.S. listing, driven by regulatory shifts in China and investor skepticism toward Hong Kong IPOs. Chaince will manage SEC filings, regulatory alignment between FDA and local standards, and investor roadshows. CEO Shi Qiu emphasized MFH’s cross-border model merging “tech-first” and institutional expertise, citing $2.1B in recent deals. The engagement highlights expanding trans-Pacific healthcare financing amid tightening biomedical rules and Asia firms’ liquidity pursuits in U.S. markets.